Cargando…

Obesity and Dose of Anti-cancer Therapy: Are We Sure to Be on the Right Track in the Precision Medicine Era?

Detalles Bibliográficos
Autores principales:	Rossi, Tania, Bandini, Erika, Balzi, William, Fabbri, Francesco, Massa, Ilaria, Maltoni, Roberta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497781/ https://www.ncbi.nlm.nih.gov/pubmed/34631747 http://dx.doi.org/10.3389/fmed.2021.725346

Ejemplares similares

Appropriateness and Economic Analysis of Conventional Circulating Biomarkers Assessment in Early Breast Cancer: A Real-World Experience from the E.Pic.A Study
por: Maltoni, Roberta, et al.
Publicado: (2022)

Making the Right Diagnosis: Slowly but Surely
por: Gajendragadkar, Parag R., et al.
Publicado: (2023)

NGAL for Preeclampsia: How Sure are We?
por: Gupta, Sachin, et al.
Publicado: (2021)

No dose adjustment of tigecycline is necessary during continuous renal replacement therapy: we are not sure
por: Honore, Patrick M., et al.
Publicado: (2020)

The challenge of sustainability in healthcare systems: cost of radiotherapy in the last month of life in an Italian cancer center
por: Rossi, Romina, et al.
Publicado: (2020)

Single-Cell NGS-Based Analysis of Copy Number Alterations Reveals New Insights in Circulating Tumor Cells Persistence in Early-Stage Breast Cancer
por: Rossi, Tania, et al.
Publicado: (2020)

Are We Sure that Adjuvant Chemotherapy is the Best Approach for Resectable Pancreatic Cancer? Are We in the Era of Neoadjuvant Treatment? A Review of Current Literature
por: Oneda, Ester, et al.
Publicado: (2019)

Sedation of Newborn Infants for the INSURE Procedure, Are We Sure?
por: de Kort, Ellen H. M., et al.
Publicado: (2013)

Inhibiting IL-6 in COVID-19: we are not sure
por: Honore, Patrick M., et al.
Publicado: (2020)

miR-9-5p as a Regulator of the Androgen Receptor Pathway in Breast Cancer Cell Lines
por: Bandini, Erika, et al.
Publicado: (2020)

Adipocytes and microRNAs Crosstalk: A Key Tile in the Mosaic of Breast Cancer Microenvironment
por: Bandini, Erika, et al.
Publicado: (2019)

Chronological age or biological age: What drives the choice of adjuvant treatment in elderly breast cancer patients?
por: Maltoni, Roberta, et al.
Publicado: (2021)

Phimosis – Are we on Right Track?
por: Manekar, Aditya Arvind, et al.
Publicado: (2022)

Making Sure That Orphan Incentives Tip the Right Way in Europe
por: Horgan, Denis, et al.
Publicado: (2022)

Will ESP block be the gold standard for breast surgery? We are not sure
por: Cassai, Alessandro De, et al.
Publicado: (2020)

Arriving at the Right Diagnosis in an Era of Precision Medicine
por: Pulido, Vina, et al.
Publicado: (2016)

Ayurveda research-are we on the right track?
por: Ghooi, Ravindra B.
Publicado: (2022)

The Sure Foundation
Publicado: (1889)

Rubella Seromarkers and Determinants of Infection among Tanzanian Children and Adolescents in Prevaccination Era: Are We in the Right Track?
por: Mirambo, Mariam M., et al.
Publicado: (2017)

Complete revascularization in coronary artery bypass grafting: How sure are we?
por: Zhou, Zhuoming, et al.
Publicado: (2021)

We need to make sure telecommuting does not exacerbate gender disparity
por: Fang, David, et al.
Publicado: (2022)

P1682: HEALTH RELATED QUALITY OF LIFE IN CHILDREN AND ADOLESCENTS WITH SICKLE CELL DISEASE: ARE WE SURE TO GET IT RIGHT? PATIENTS AND PARENTS MIGHT HAVE DIFFERENT OPINIONS.
por: Fantasia, Desiré, et al.
Publicado: (2023)

Are We Sure We Fully Understand What an Infodemic Is? A Global Perspective on Infodemiological Problems
por: Rovetta, Alessandro, et al.
Publicado: (2022)

The role of forests in the EU climate policy: are we on the right track?
por: Korosuo, Anu, et al.
Publicado: (2023)

Biobanking of Exosomes in the Era of Precision Medicine: Are We There Yet?
por: Mora, Edna M., et al.
Publicado: (2015)

Circulating Tumor Cells as a Tool to Untangle the Breast Cancer Heterogeneity Issue
por: Rossi, Tania, et al.
Publicado: (2021)

Early Detection and Investigation of Extracellular Vesicles Biomarkers in Breast Cancer
por: Bandini, Erika, et al.
Publicado: (2021)

Metabolic activity of neutrophils is elevated in chronic obstructive pulmonary disease: Are we sure?
por: Ghosh, Baishakhi
Publicado: (2016)

COVID-19 Deaths: Are We Sure It Is Pneumonia? Please, Autopsy, Autopsy, Autopsy!
por: Pomara, Cristoforo, et al.
Publicado: (2020)

Are we sure that the neurological impact of COVID 19 in childhood has not been underestimated?
por: Principi, Nicola, et al.
Publicado: (2021)

Late primary angioplasty (beyond 12 h): are we sure it should be avoided?
por: Bolognese, Leonardo
Publicado: (2021)

Higher PEEP in intubated COVID-19-associated ARDS patients? We are not sure
por: Yaroshetskiy, Andrey I., et al.
Publicado: (2022)

The Epidemic of Hip Fractures: Are We on the Right Track?
por: Hartholt, Klaas A., et al.
Publicado: (2011)

Tobacco and Cardiovascular Diseases: Are We on the Right Track?
por: Shrivastava, Saurabh R., et al.
Publicado: (2019)

Pneumococcal Disease Prevention: Are We on the Right Track?
por: Principi, Nicola, et al.
Publicado: (2021)

Translational Research in the Era of Precision Medicine: Where We Are and Where We Will Go
por: De Maria Marchiano, Ruggero, et al.
Publicado: (2021)

The sure hand of god
por: Caldwell, Erskine, 1903-
Publicado: (1953)

Scan? Cure? Sure!
Publicado: (2011)

Sure to Have Support
Publicado: (1897)

Lung ultrasound and B-lines quantification inaccuracy: B sure to have the right solution
por: Corradi, F., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9ce7tvkvdhccuqr3lm315itaku